Efficacy and Safety Evaluation of Prebiotics Combined With Quadruple Probiotics in Improving Functional Constipation.
1 other identifier
interventional
60
1 country
1
Brief Summary
In this study, we will evaluate the efficacy of prebiotics combined with quadruple probiotics in the treatment of functional constipation through an open RCT study. The experimental group received lifestyle guidance and combined intervention of prebiotics and quadruple probiotics at the same time. The patients took the combination of prebiotics and probiotics twice a day during the treatment period. The control group received only lifestyle instruction. At the same time, to evaluate the safety of probiotics combined with quadruple probiotics in the treatment of functional constipation, and provide a new treatment plan for clinical treatment of functional constipation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2024
CompletedFirst Posted
Study publicly available on registry
February 26, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedMay 1, 2024
March 1, 2024
1.1 years
February 18, 2024
April 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the number of fully autonomous bowel movements per week at the end of treatment
Change in the number of fully autonomous bowel movements per week at the end of treatment
A month after treatment
Study Arms (2)
Prebiotics and probiotics,life-style
EXPERIMENTALTake 3.5g prebiotic +2g probiotic twice a day before meals; At the same time, lifestyle guidance is given, including adjusting dietary structure, increasing the intake of foods high in dietary fiber and moderate exercise
life-style
OTHERlifestyle guidance is given, including adjusting dietary structure, increasing the intake of foods high in dietary fiber and moderate exercise
Interventions
Take 3.5g prebiotic +2g prebiotic twice a day before meals; At the same time, lifestyle guidance is given, including adjusting dietary structure, increasing the intake of foods high in dietary fiber and moderate exercise
lifestyle guidance is given, including adjusting dietary structure, increasing the intake of foods high in dietary fiber and moderate exercise
Eligibility Criteria
You may qualify if:
- Age: between 18 and 60 years old
- Functional constipation was diagnosed using Rome IV criteria.
- No other relevant medications that may affect the gut microbiota before the start of the experiment
- Ability to participate
- Consent to participate in the study
You may not qualify if:
- Organic constipation (such as intestinal obstruction, bowel cancer, etc.)
- Outlet obstructive constipation
- Previous abdominal, rectal, or perianal surgery except cholecystectomy, appendectomy, tubal ligation, and cesarean section
- Patients with constipation-oriented irritable bowel syndrome (IBS-C) or functional abdominal pain syndrome who meet Rome IV criteria
- a serious mental illness or any medical condition related to it
- Diseases of the small or large intestine, such as ulcerative colitis and Crohn's disease
- There are serious important organs such as respiratory, heart, liver, kidney and other functional insufficiency
- Use probiotics, prebiotics and/or Biostime within 1 month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Xiamen Univisity
Xiamen, Fujian, 350000, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 18, 2024
First Posted
February 26, 2024
Study Start
May 1, 2024
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
May 1, 2024
Record last verified: 2024-03